Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
About this item
Full title
Author / Creator
Prager, Gerald W. , Taieb, Julien , Fakih, Marwan , Ciardiello, Fortunato , Van Cutsem, Eric , Elez, Elena , Cruz, Felipe M. , Wyrwicz, Lucjan , Stroyakovskiy, Daniil , Pápai, Zsuzsanna , Poureau, Pierre-Guillaume , Liposits, Gabor , Cremolini, Chiara , Bondarenko, Igor , Modest, Dominik P. , Benhadji, Karim A. , Amellal, Nadia , Leger, Catherine , Vidot, Loïck , Tabernero, Josep and SUNLIGHT Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a previous phase 3 trial, treatment with trifluridine-tipiracil (FTD-TPI) prolonged overall survival among patients with metastatic colorectal cancer. Preliminary data from single-group and randomized phase 2 trials suggest that treatment with FTD-TPI in addition to bevacizumab has the potential to extend survival.
We randomly assigned, in a...
Alternative Titles
Full title
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Authors, Artists and Contributors
Author / Creator
Taieb, Julien
Fakih, Marwan
Ciardiello, Fortunato
Van Cutsem, Eric
Elez, Elena
Cruz, Felipe M.
Wyrwicz, Lucjan
Stroyakovskiy, Daniil
Pápai, Zsuzsanna
Poureau, Pierre-Guillaume
Liposits, Gabor
Cremolini, Chiara
Bondarenko, Igor
Modest, Dominik P.
Benhadji, Karim A.
Amellal, Nadia
Leger, Catherine
Vidot, Loïck
Tabernero, Josep
SUNLIGHT Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2809002062
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2809002062
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2214963
